JP Morgan Chase
IH

JP Morgan Chase’s iHuman IH Stock Holding History

JP Morgan Chase’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-143,857
Closed -$316K – 6762
2022
Q3 		$316K Hold
143,857
– – ﹤0.01% 4724
2022
Q2 		$340K Hold
143,857
– – ﹤0.01% 4777
2022
Q1 		$308K Hold
143,857
– – ﹤0.01% 4968
2021
Q4 		$403K Sell
143,857
-85,133
-37% -$365K ﹤0.01% 4965
2021
Q3 		$1.08M Sell
228,990
-48,788
-18% -$363K ﹤0.01% 4252
2021
Q2 		$2.87M Buy
277,778
+6,324
+2% +$69.7K ﹤0.01% 3523
2021
Q1 		$3.4M Buy
271,454
+17,907
+7% +$316K ﹤0.01% 3296
2020
Q4 		$4.59M Buy
+253,547
New +$5.65M ﹤0.01% 2880

Other funds holding IH

APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's IH Position: Q4 2022 in Review

JP Morgan Chase sold out of iHuman (IH) in Q4 2022, closing a stake of 143,857 shares — an estimated $316K sold.

JP Morgan Chase first reported a position in IH in Q4 2020 and held it in 8 quarters. The position peaked at $4.59M in Q4 2020. 7 funds tracked by Wall St. Rank hold IH as of Q4 2022.

  • JP Morgan Chase reported no remaining iHuman position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 143,857 iHuman shares in Q4 2022, an estimated $316K.
  • JP Morgan Chase first reported a position in iHuman in Q4 2020 and held it in 8 quarters.
  • JP Morgan Chase's iHuman position peaked at $4.59M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held iHuman as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.